三生三世十里桃花

华森制药：收到药品再注册批准通知书_我的网站

A |     In a significant development, producer Bhushan Kumar of T-Series and filmmaker Vivek Agnihotri have officially announced their new collaboration titled Operation Sindoor. The upcoming film is set to bring to the big screen the story of India's targeted military strikes on terror infrastructure in Pakistan and Pakistan-occupied Kashmir. The project draws its inspiration from the real-life military codename used during these strikes. The operations were a direct response to the tragic 2025 Pahalgam terror attack in Jammu and Kashmir, which resulted in the loss of 26 lives, the majority of whom were tourists.           The film finds its foundation in the book Operation Sindoor: The Untold Story of India's Deep Strikes Inside Pakistan, authored by Lt Gen K.J.S. 'Tiny' Dhillon (Retd). Directed by Vivek Agnihotri, the movie will be a joint production between T-Series and Agnihotri’s I Am Budha Productions. The makers have described the project as a cinematic tribute to a defining moment in India’s history, highlighting the nation’s strategic resolve, precision, and courage. Sharing his thoughts on the project, Bhushan Kumar said, "Some stories are not chosen, they choose you. Operation Sindoor is one such story, one that demands to be told with honesty, courage, and responsibility. This is not just a film. It is a revelation. When a nation goes through events of such magnitude, it becomes important to document them truthfully."          Vivek Agnihotri, known for directing hard-hitting films like The Kashmir Files and The Tashkent Files, explained the depth of the research involved. He shared, "This is not just a film. It is a revelation. With Operation Sindoor, India has not just taken revenge for the Pahalgam terror attack and punished Pakistan, but it has also demonstrated its might in modern warfare." Agnihotri further explained that the team conducted extensive ground-level research alongside various wings of the Indian Armed Forces. According to the director, the goal is to show the audience the how and why behind the events. He added, "What emerges is a reality far more complex, far more precise, and far more unsettling than what is available in the public domain.”           Agnihotri expressed his commitment to authenticity, saying that his effort is to bring this story of professionalism and strategic clarity to the audience as an edge-of-the-seat cinematic experience. He concluded by saying, "My intention is not to create noise, but to confront it—with facts, with clarity, and the magic of cinema."Also Read: Vivek Agnihotri’s The Delhi Files gets a release date。    华森制药8月25日公告称，公司近日收到重庆市药品监督管理局核准签发的关于产品注射用二乙酰氨乙酸乙二胺(0.2g和0.4g)的《药品再注册批准通知书》。

B | 该药品适用于预防和治疗各种原因出血。本次获得再注册批准将确保药品正常生产和销售，短期内不会对公司经营业绩产生重大影响。

Current article:http://05pe6.recuigoutoubaozukai.pics/t5q4/l9tugz5.html

Published on:21:34:33